Sign Up to like & get
recommendations!
1
Published in 2017 at "Expert Review of Neurotherapeutics"
DOI: 10.1080/14737175.2017.1268054
Abstract: There have been an increasing number of publications on new medications for Alzheimer’s disease (AD). Results from the first study in mild-to-moderate stages of AD using LMTM which inhibits the tau protein aggregation were recently…
read more here.
Keywords:
expert review;
alzheimer disease;
review neurotherapeutics;
disease ... See more keywords